Interface Clinical Services, an IQVIA Business, Announces Innovative Collaboration with UCLPartners

Using proven frameworks alongside clinical expertise, this collaboration will support the NHS in adopting a proactive, population health approach to managing long-term conditions.

The proactive care frameworks, developed by UCLPartners and shared as part of this collaboration, support clinicians to prioritise patients at highest risk of deterioration, optimise their care and manage workloads.  The frameworks focus on conditions including atrial fibrillation, hypertension, primary and secondary prevention of CVD, type 2 diabetes, heart failure, asthma and COPD.

To help embed these frameworks, IQVIA Interface will provide additional clinical capacity, knowledge and expertise through trained pharmacists to support the delivery of proactive patient care.

Together this collaboration will mean that multidisciplinary teams (MDT) across primary care working in proactive care, including GPs, nurses, and pharmacists will have increased access to mentorship, education, and training opportunities.

Proactive patient care improves health outcomes and reduces hospital admissions by addressing health issues early. This approach leads to cost savings and enhances patient experience, making it vital for the efficiency and effectiveness of the NHS. By incorporating ongoing workstreams and creating an educational legacy this collaboration can support a sustainable approach to proactive care.

ENDS

Notes to editors

UCLPartners are a health innovation partnership. Their mission is to help five million people from North London to the Essex coast live longer, healthier lives. They focus on the health problems that affect the most vulnerable people in their population. They enable new life-changing treatments and technologies to reach them faster, by translating clinical research into practice and by speeding up promising innovations and solutions.

Interface Clinical Services, an IQVIA Business supports primary care with the management of long-term conditions, disease prevalence, and clinical improvement programmes.

Collaborating across all levels of primary care, their national team of clinical pharmacists can provide additional clinical capacity, mentorship, education, and proactive patient reviews to improve access for patients.

As an NHS business partner, IQVIA  Interface pharmacists can support primary care to improve health outcomes, reduce health inequalities, and provide targeted resources to deliver proactive care. Working with around 50% of all GP practices in England in the last two years across key therapy areas, including asthma, COPD, CVD, diabetes, and lipid management, Interface utilises data insight capabilities and clinical expertise to enhance outcomes for patients and the NHS.